IBDEI0TE ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14514,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,14514,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,14515,0)
 ;;=V16.43^^90^861^11
 ;;^UTILITY(U,$J,358.3,14515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14515,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,14515,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,14515,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,14516,0)
 ;;=V19.5^^90^861^13
 ;;^UTILITY(U,$J,358.3,14516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14516,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,14516,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,14516,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,14517,0)
 ;;=V19.2^^90^861^14
 ;;^UTILITY(U,$J,358.3,14517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14517,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,14517,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,14517,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,14518,0)
 ;;=V17.3^^90^861^16
 ;;^UTILITY(U,$J,358.3,14518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14518,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,14518,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,14518,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,14519,0)
 ;;=V16.6^^90^861^17
 ;;^UTILITY(U,$J,358.3,14519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14519,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,14519,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,14519,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,14520,0)
 ;;=V18.61^^90^861^19
 ;;^UTILITY(U,$J,358.3,14520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14520,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,14520,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,14520,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,14521,0)
 ;;=V17.0^^90^861^20
 ;;^UTILITY(U,$J,358.3,14521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14521,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,14521,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,14521,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,14522,0)
 ;;=V19.4^^90^861^21
 ;;^UTILITY(U,$J,358.3,14522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14522,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,14522,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,14522,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,14523,0)
 ;;=V17.1^^90^861^22
 ;;^UTILITY(U,$J,358.3,14523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14523,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,14523,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,14523,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,14524,0)
 ;;=V16.8^^90^861^12
 ;;^UTILITY(U,$J,358.3,14524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14524,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,14524,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,14524,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,14525,0)
 ;;=V11.1^^90^861^24
 ;;^UTILITY(U,$J,358.3,14525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14525,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,14525,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,14525,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,14526,0)
 ;;=V15.89^^90^861^46
 ;;^UTILITY(U,$J,358.3,14526,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14526,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,14526,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,14526,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,14527,0)
 ;;=V11.3^^90^861^25
 ;;^UTILITY(U,$J,358.3,14527,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14527,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,14527,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,14527,2)
 ;;=^295252
